1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Squamous Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Squamous Non-Small Cell Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Squamous Non-Small Cell Lung Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Squamous Non-Small Cell Lung Cancer 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Squamous Non-Small Cell Lung Cancer 33
Sep 09, 2013: Oncolytics Biotech Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer 33
Aug 13, 2013: Eli Lilly and Company's Phase III study of necitumumab meets primary endpoint 33
Jun 04, 2013: Debiopharm Announces Additional Phase I Clinical Trial Evaluating Debio 1143 Combined With Chemotherapies For Patients With Selected Solid Malignancies 33
May 23, 2013: OncoGenex Pharma Announces Plans For Initiation Of Cedar Clinical Trial Evaluating OGX-427 In Combination With Chemotherapy In Advanced Squamous Cell Lung Cancer 34
Mar 28, 2013: Oncolytics Biotech Meets Primary Overall Statistical Endpoint In US Phase II Study Of Reolysin In Squamous Cell Lung Cancer 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
AbbVie Inc. 41
Clinical Trial Overview of AbbVie Inc. 41
Novartis AG 42
Clinical Trial Overview of Novartis AG 42
GlaxoSmithKline plc 43
Clinical Trial Overview of GlaxoSmithKline plc 43
Debiopharm International S.A. 44
Clinical Trial Overview of Debiopharm International S.A. 44
Agennix AG 45
Clinical Trial Overview of Agennix AG 45
Clinical Trial Overview of Top Institutes / Government 46
National Cancer Institute 46
Clinical Trial Overview of National Cancer Institute 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Cancer Institute Hospital Japanese Foundation for Cancer Research 48
Clinical Trial Overview of Cancer Institute Hospital Japanese Foundation for Cancer Research 48
Rigshospitalet 49
Clinical Trial Overview of Rigshospitalet 49
Sarah Cannon Research Institute 50
Clinical Trial Overview of Sarah Cannon Research Institute 50
Wake Forest University 51
Clinical Trial Overview of Wake Forest University 51
Hiroshima University Hospital 52
Clinical Trial Overview of Hiroshima University Hospital 52
Eastern Cooperative Oncology Group 53
Clinical Trial Overview of Eastern Cooperative Oncology Group 53
Samsung Medical Center 54
Clinical Trial Overview of Samsung Medical Center 54
Five Key Clinical Profiles 55
Appendix 158
Abbreviations 158
Definitions 158
Research Methodology 159
Secondary Research 159
About GlobalData 160
Contact Us 160
Disclaimer 160
Source 161

List of Tables
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Squamous Non-Small Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 36
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 37
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 38
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 39
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 40
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 41
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 42
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 43
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Debiopharm International S.A., 2014* 44
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Agennix AG, 2014* 45
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 46
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 47
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Institute Hospital Japanese Foundation for Cancer Research, 2014* 48
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 49
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2014* 50
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 51
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2014* 52
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014* 53
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 54

List of Figures
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Squamous Non-Small Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 159

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


Download Unlimited Documents from Trusted Public Sources

Antidepressant Market and Bipolar Disorder Statistics in the UK

  • January 2017
    9 pages
  • Antidepressant  

    Bipolar Disorde...  

    Depression  

  • United Kingdom  

View report >

Therapy Market in Uganda

  • January 2017
    22 pages
  • Therapy  

  • Uganda  

    Africa  

View report >

Therapy Market in South Africa

  • January 2017
    12 pages
  • Therapy  

  • South Africa  

    Africa  

View report >

Therapy Market

24 hours ago

Diabetes Statistics

24 hours ago

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.